246 related articles for article (PubMed ID: 29097143)
21. Role of the kringle-like domain in glycoprotein NMB for its tumorigenic potential.
Xie R; Okita Y; Ichikawa Y; Fikry MA; Huynh Dam KT; Tran STP; Kato M
Cancer Sci; 2019 Jul; 110(7):2237-2246. PubMed ID: 31127873
[TBL] [Abstract][Full Text] [Related]
22. Glycoprotein nonmetastatic melanoma protein B impacts the malignant potential of bladder cancer cells through its hem-immunoreceptor tyrosine-based activation motif.
Kimura T; Okita Y; Nagumo Y; Chin JM; Fikry MA; Shiga M; Kandori S; Kawahara T; Suzuki H; Nishiyama H; Kato M
Pathol Int; 2024 May; 74(5):262-273. PubMed ID: 38501371
[TBL] [Abstract][Full Text] [Related]
23. Phase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with locally advanced or metastatic breast cancer.
Bendell J; Saleh M; Rose AA; Siegel PM; Hart L; Sirpal S; Jones S; Green J; Crowley E; Simantov R; Keler T; Davis T; Vahdat L
J Clin Oncol; 2014 Nov; 32(32):3619-25. PubMed ID: 25267761
[TBL] [Abstract][Full Text] [Related]
24. EMERGE: A Randomized Phase II Study of the Antibody-Drug Conjugate Glembatumumab Vedotin in Advanced Glycoprotein NMB-Expressing Breast Cancer.
Yardley DA; Weaver R; Melisko ME; Saleh MN; Arena FP; Forero A; Cigler T; Stopeck A; Citrin D; Oliff I; Bechhold R; Loutfi R; Garcia AA; Cruickshank S; Crowley E; Green J; Hawthorne T; Yellin MJ; Davis TA; Vahdat LT
J Clin Oncol; 2015 May; 33(14):1609-19. PubMed ID: 25847941
[TBL] [Abstract][Full Text] [Related]
25. Glycoprotein non-metastatic b (GPNMB): A metastatic mediator and emerging therapeutic target in cancer.
Maric G; Rose AA; Annis MG; Siegel PM
Onco Targets Ther; 2013; 6():839-52. PubMed ID: 23874106
[TBL] [Abstract][Full Text] [Related]
26. Glycoprotein nonmetastatic melanoma protein B (GPNMB) as a novel neuroprotective factor in cerebral ischemia-reperfusion injury.
Nakano Y; Suzuki Y; Takagi T; Kitashoji A; Ono Y; Tsuruma K; Yoshimura S; Shimazawa M; Iwama T; Hara H
Neuroscience; 2014 Sep; 277():123-31. PubMed ID: 25010402
[TBL] [Abstract][Full Text] [Related]
27. CCN3/NOV promotes metastasis and tumor progression via GPNMB-induced EGFR activation in triple-negative breast cancer.
Son S; Kim H; Lim H; Lee JH; Lee KM; Shin I
Cell Death Dis; 2023 Feb; 14(2):81. PubMed ID: 36737605
[TBL] [Abstract][Full Text] [Related]
28. CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma.
Tse KF; Jeffers M; Pollack VA; McCabe DA; Shadish ML; Khramtsov NV; Hackett CS; Shenoy SG; Kuang B; Boldog FL; MacDougall JR; Rastelli L; Herrmann J; Gallo M; Gazit-Bornstein G; Senter PD; Meyer DL; Lichenstein HS; LaRochelle WJ
Clin Cancer Res; 2006 Feb; 12(4):1373-82. PubMed ID: 16489096
[TBL] [Abstract][Full Text] [Related]
29. Macrophage-Associated Osteoactivin/GPNMB Mediates Mesenchymal Stem Cell Survival, Proliferation, and Migration Via a CD44-Dependent Mechanism.
Yu B; Sondag GR; Malcuit C; Kim MH; Safadi FF
J Cell Biochem; 2016 Jul; 117(7):1511-21. PubMed ID: 26442636
[TBL] [Abstract][Full Text] [Related]
30. [Expression of glycoprotein non-metastatic melanoma protein B in prostate cancer and its significance].
Xiao YB; Qiao ZG; Zhang XW; Liu ZH; Xie J; Hao YC; Yu WD; Xu T; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Aug; 43(4):496-9. PubMed ID: 21844952
[TBL] [Abstract][Full Text] [Related]
31. GPNMB expression in uveal melanoma: a potential for targeted therapy.
Williams MD; Esmaeli B; Soheili A; Simantov R; Gombos DS; Bedikian AY; Hwu P
Melanoma Res; 2010 Jun; 20(3):184-90. PubMed ID: 20375921
[TBL] [Abstract][Full Text] [Related]
32. Glycoprotein Nonmetastatic Melanoma B (Gpnmb)-Positive Macrophages Contribute to the Balance between Fibrosis and Fibrolysis during the Repair of Acute Liver Injury in Mice.
Kumagai K; Tabu K; Sasaki F; Takami Y; Morinaga Y; Mawatari S; Hashimoto S; Tanoue S; Kanmura S; Tamai T; Moriuchi A; Uto H; Tsubouchi H; Ido A
PLoS One; 2015; 10(11):e0143413. PubMed ID: 26599547
[TBL] [Abstract][Full Text] [Related]
33. GPNMB: a potent inducer of immunosuppression in cancer.
Lazaratos AM; Annis MG; Siegel PM
Oncogene; 2022 Oct; 41(41):4573-4590. PubMed ID: 36050467
[TBL] [Abstract][Full Text] [Related]
34. Preclinical PET imaging of glycoprotein non-metastatic melanoma B in triple negative breast cancer: feasibility of an antibody-based companion diagnostic agent.
Marquez-Nostra BV; Lee S; Laforest R; Vitale L; Nie X; Hyrc K; Keler T; Hawthorne T; Hoog J; Li S; Dehdashti F; Ma CX; Lapi SE
Oncotarget; 2017 Nov; 8(61):104303-104314. PubMed ID: 29262642
[TBL] [Abstract][Full Text] [Related]
35. GPNMB promotes proliferation of developing eosinophils.
Hwang SM; Kang JH; Kim BK; Uhm TG; Kim HJ; Lee HH; Binas B; Chung IY
J Biochem; 2017 Aug; 162(2):85-91. PubMed ID: 28104809
[TBL] [Abstract][Full Text] [Related]
36. Clinical Significance of Glycoprotein Non-metastatic B and Its Association with EGFR/HER2 in Gastrointestinal Cancer.
Tajima JY; Futamura M; Gaowa S; Mori R; Tanahashi T; Tanaka Y; Matsuhashi N; Takahashi T; Yamaguchi K; Miyazaki T; Yoshida K
J Cancer; 2018; 9(2):358-366. PubMed ID: 29344282
[TBL] [Abstract][Full Text] [Related]
37. Targeting Glycoprotein NMB With Antibody-Drug Conjugate, Glembatumumab Vedotin, for the Treatment of Osteosarcoma.
Roth M; Barris DM; Piperdi S; Kuo V; Everts S; Geller D; Houghton P; Kolb EA; Hawthorne T; Gill J; Gorlick R
Pediatr Blood Cancer; 2016 Jan; 63(1):32-8. PubMed ID: 26305408
[TBL] [Abstract][Full Text] [Related]
38.
Makhlouf A; Hajdu I; Hartimath SV; Alizadeh E; Wharton K; Wasan KM; Badea I; Fonge H
Mol Pharm; 2019 Feb; 16(2):542-551. PubMed ID: 30605337
[TBL] [Abstract][Full Text] [Related]
39. Expression of glycoprotein nonmetastatic melanoma protein B in macrophages infiltrating injured mucosa is associated with the severity of experimental colitis in mice.
Sasaki F; Kumagai K; Uto H; Takami Y; Kure T; Tabu K; Nasu Y; Hashimoto S; Kanmura S; Numata M; Moriuchi A; Sakiyama T; Tsubouchi H; Ido A
Mol Med Rep; 2015 Nov; 12(5):7503-11. PubMed ID: 26458492
[TBL] [Abstract][Full Text] [Related]
40. [Expression and clinical significance of glycoprotein non-metastatic melanoma protein B in human renal cell carcinoma].
Qin CP; Xiao YB; Liu ZH; Xie J; Yuan YQ; Hao YC; Xu T; Wang XF
Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Jun; 45(3):448-51. PubMed ID: 23774926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
